Yenidoğanda Fototerapinin IL-6 ve IL-8 Düzeyine Etkisi

Anderson NB, Calkins KL. Neonatal Indirect Hyperbilirubinemia. Neoreviews. 2020;21(11):e749-e760. doi: 10.1542/neo.21-11-e749.
Sirota L, Straussberg R, Gurary N, et al. Phototherapy for neonatal hyperbilirubinemia affects cytokine production by peripheral blood mononuclear cells. European Journal of Pediatrics. 1999;158(11):910-3. doi: 10.1007/s004310051240.
Procianoy RS, Silveira RC, Fonseca LT, et al. The influence of phototherapy on serum cytokine concentrations in newborn infants. American Journal of Perinatology. 2010 ;27(5):375-9. doi: 10.1055/s-0029-1243311.
Eichberger J, Resch E, Resch B. Diagnosis of Neonatal Sepsis: The Role of Inflammatory Markers. Frontiers in Pediatrics. 2022;10:840288. doi: 10.3389/fped.2022.840288.
Glaser MA, Hughes LM, Jnah A, et al. Neonatal Sepsis: A Review of Pathophysiology and Current Management Strategies. Advances in Neonatal Care. 2021;21(1):49-60. doi: 10.1097/ANC.0000000000000769.
Santana Reyes C, García-Muñoz F, Reyes D,et al. Role of cytokines (interleukin-1beta, 6, 8, tumour necrosis factor-alpha, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatrica. 2003;92(2):221-7. doi: 10.1111/j.1651-2227.2003.tb00530.x.
Yurdakök M. Hiperbilirubinemide ışık ve ilaç tedavisi. In: Yurdakök M (ed.) Katkı Pediatri Dergisi. Ankara: Hacettepe Üniversitesi Tıp Fakültesi; 1995 (5). p. 725-733.
Wang J, Guo G, Li A, et al. Challenges of phototherapy for neonatal hyperbilirubinemia (Review). Experimental and therapeutic medicine. 2021;21(3):231. doi: 10.3892/etm.2021.9662.
Dağoğlu T, Ovalı F. İndirekt hiperbilirubinemi. In: Dağoğlu T (ed.) Neonataloji. İstanbul: Nobel Tıp Kitabevleri Ltd; 2000 (50). p. 453-455.
Halomek LP, Stevenson DK. Neonatal Jaundice and Liver Disease. In: Fanaroff AA,Martin RJ (eds.). Neonatal-Perinatal Medicine Vol 2. 6th ed. Disease of the fetus and infant. St.Louis, USA: Mosby; 1997; 45. p. 1365-1369.
Ebbesen F, Agati G, Pratesi R. Phototherapy with turquoise versus blue light. Archives of disease in childhood. Fetal and neonatal edition. 2003;88 (5):F430-1. doi: 10.1136/fn.88.5.f430.
Pezzati M, Fusi F, Dani C et al. Changes in skin temperature of hyperbilirubinemic newborns under phototherapy: conventional versus fiberoptic device. American Journal of Perinatology. 2002;19 (8):439-44. doi: 10.1055/s-2002-36839.
Lin WH, Chen SJ, Tang RB, et al. Comparison of conventional phototherapy and fiberoptic phototherapy in the very-low-body-weight infants. Acta paediatrica Taiwanica. 2001 ;42(3):141-4.
Dani C, Bertini G, Martelli E, et al. Effects of phototherapy on cerebral haemodynamics in preterm infants: is fibre-optic different from conventional phototherapy? Developmental medicine and child neurology. 2004;46(2):114-8. doi: 10.1017/s0012162204000222.
Novoa RH, Huaman K, Caballero P. Light-Emitting Diode (LED) Phototherapy versus Non-LED Phototherapy Devices for Hyperbilirubinemia in Neonates: A Systematic Review and Meta-analysis. American Jounal of Perinatology. 2023; 40(15):1618-1628. doi: 10.1055/a-1827-7607.
Grünhagen DJ, de Boer MG, de Beaufort AJ, et al. Transepidermal water loss during halogen spotlight phototherapy in preterm infants. Pediatr Research. 2002;51(3):402-5. doi: 10.1203/00006450-200203000-00022.
Küçükhödük Ş. Hiperbilirubinemi. In: Küçükhödük Ş (ed.) Yenidoğan ve Hastalıkları. Ankara: Feryal Matbaası;1994. p. 409-10.
Boo NY, Lee HT. Randomized controlled trial of oral versus intravenous fluid supplementation on serum bilirubin level during phototherapy of term infants with severe hyperbilirubinaemia. Journal of Paediatrics and Child Health. 2002;38(2):151-5. doi: 10.1046/j.1440-1754.2002.00746.x.
Wang J, Guo G, Li A,et al. Challenges of phototherapy for neonatal hyperbilirubinemia (Review). Experimental and therapeutic medicine 2021;21(3):231. doi: 10.3892/etm.2021.9662.
Cohen AN, Ostrow JD. New concepts in phototherapy: photoisomerization of bilirubin IX alpha and potential toxic effects of light. Pediatrics. 1980; 65(4):740-50.
Knobloch E, Hodr R. Metabolism of bilirubin and riboflavin in the course of phototherapy for hyperbilirubinaemia in the newborns. Czechoslovak Medicine. 1989;12(3):134-44.
Durum SK, Openheim JJ. Proinflammatory cytokines and immunity. In: Paul WE (ed). Fundemental Immunology. 3rd ed. New York: Raven Press Ltd; 1993. p. 801-835.
Kılıçturgay K. İmmunolojiye Giriş. 3.basım. Bursa: Güneş ve Nobel Tıp Kitabevleri 1994.
Brik M, Aguar M, Valiente A, et al. Cervical IL-6 and pIGFBP-1 and the prediction of neonatal outcome in symptomatic preterm labour. Journal of Maternal-Fetal Neonatal Medicine. 2014 ;27(12):1241-7. doi: 10.3109/14767058.2013.854326.
Mehr SS, Doyle LW, Rice GE, et al. Interleukin-6 and interleukin-8 in newborn bacterial infection. American Journal of Perinatology. 2001;18 (6):313-24. doi: 10.1055/s-2001-17857.
Krueger M, Nauck MS, Sang S, et al. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biology of the Neonate. 2001;80 (2):118-23. doi: 10.1159/000047130.
Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunological reviews. 1992 ;127:25-50. doi: 10.1111/j.1600-065x.1992.tb01407.x.
Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;77(8):1627-52.
29.Hirano T, Akira S, Taga T, et al. Biological and clinical aspects of interleukin 6. Immunology Today. 1990 ;11(12):443-9. doi: 10.1016/0167-5699(90)90173-7.
Abbas AK, Lichtman AH, Pober JS. Cellular and molecular İmmunology. USA: WB Saunders Company, 1997.
Kishimoto T. The biology of interleukin-6. Blood. 1989;74(1):1-10.
Alam R. Chemokines in cell movement and inflammation Rosenwasser LJ, Borish L. Cytokines in allergic inflammation. Church MK, Shute JK, Sampson AP. Mast cell-derivatedmediators. Hirota K, Adolphson CR, Gleich GC. Biology of eosinophils. In: Adkinson NF,Yunginger JW, Busse WW, Bachner BS, Holgate ST, Simons FER (eds) Middleton’s Allergy. 6th ed. USA: Mosby; 2003.p. 164-165, 138-139, 205, 314.
Chiesa C, Signore F, Assumma M, et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders. Clinical Chemistry. 2001 ; 47(6):1016-22.
Castell JV, Gómez-Lechón MJ, David M, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letters. 1989;242(2):237-9. doi: 10.1016/0014-5793(89)80476-4.
Richards C, Gauldie J, Baumann H. Cytokine control of acute phase protein expression. European Cytokine Network. 1991;2(2):89-98.
Groll AH, Meiser A, Weise M, et al. Interleukin 6 as early mediator in neonatal sepsis. Pediatric Infectious Disease Journal. 1992; 11(6):496-8.
Rusconi F, Parizzi F, Garlaschi L, et al. Interleukin 6 activity in infants and children with bacterial meningitis. The Collaborative Study on Meningitis. Pediatric Infectious Disease Journal. 1991;10(2):117-21. doi: 10.1097/00006454-199102000-00008.
Sullivan JS, Kilpatrick L, Costarino AT Jr, et al. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. The Journal of Pediatrics. 1992;120(4 Pt 1):510-5. doi: 10.1016/s0022-3476(05)82476-x.
Grebenciucova E, VanHaerents S. Interleukin 6: at the interface of human health and disease. Frontierss in Immunology. 2023;14:1255533. doi: 10.3389/fimmu.2023.1255533.
Oppenheim JJ, Ruscetti FW. Cytokines. In: Stites DP, Terr AI, Parslow TG (eds.) Medical İmmunology. 9th ed. USA: Appleton& Lange 1997;10. p. 162-164.
Parham P. The Immune System. Londra : Garland Publishing 2000; p. 216.
David R, Machova Z, Beck-Sickinger AG. Semisynthesis and application of carboxyfluorescein-labelled biologically active human interleukin-8. Biological Chemistry. 2003;384(12):1619-30. doi: 10.1515/BC.2003.180.
Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: An evolving chemokine. Cytokine. 2022 ;153:155828. doi: 10.1016/j.cyto.2022.155828.
Tang RB, Chen SJ. Evaluation of serum interleukin-8 as a marker of disease activity in acute asthma in children. The Journal of Asthma 2000 ;37(5):409-13. doi: 10.3109/02770900009055466.
Kurt A, Aygun AD, Kurt AN, et al. Use of phototherapy for neonatal hyperbilirubinemia affects cytokine production and lymphocyte subsets. Neonatology. 2009;95(3):262-6. doi: 10.1159/000171216.
Procianoy RS, Silveira RC, Fonseca LT,et al. The influence of phototherapy on serum cytokine concentrations in newborn infants. American Journal of Perinatology. 2010 ;27(5):375-9. doi: 10.1055/s-0029-1243311.
Araneo BA, Dowell T, Moon HB, et al. Regulation of murine lymphokine production in vivo. Ultraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism. The Journal of Immunology. 1989;143 (6):1737-44.
Kirnbauer R, Köck A, Neuner P, et al. Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. The Journal of Investigative Dermatology. 1991;96(4):484-9. doi: 10.1111/1523-1747.ep12470181.
Köck A, Schwarz T, Kirnbauer R, Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. The Journal of Experimental Medicine. 1990;172(6):1609-14. doi: 10.1084/jem.172.6.1609.
Gallo RL, Staszewski R, Sauder DN, et al. Regulation of GM-CSF and IL-3 production from the murine keratinocyte cell line PAM 212 following exposure to ultraviolet radiation. Journal of Investigative Dermatology. 1991;97 (2):203-9. doi: 10.1111/1523-1747.ep12479676.
Kupper TS, Chua AO, Flood P, et al. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. The Journal of Clinical Investigation. 1987 ;80(2):430-6. doi: 10.1172/JCI113090.
Bhadri S, Thapa P, Chen Y, et al. Evidence for microvesicle particles in UVB-mediated IL-8 generation in keratinocytes. Journal of Clinical Investigative Dermatology. 2021 ;9(2):10.13188/2373-1044.1000076. doi: 10.13188/2373-1044.1000076.
Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. Journal of Investigative Dermatology. 1995;104 (1):3-6. doi: 10.1111/1523-1747.ep12613446.
Rivas JM, Ullrich SE. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. Journal of Immunology. 1992;149(12):3865-71.
Bos JD, Zonneveld I, Das PK, et al. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. Journal of Investigative Dermatology. 1987;88(5):569-73. doi: 10.1111/1523-1747.ep12470172.
Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 ;75(1):40-7.
Schwarz T, Luger TA. Effect of UV irradiation on epidermal cell cytokine production. Journal of photochemistry and photobiology.1989;4(1):1-13. doi: 10.1016/1011-1344(89)80097-1.
Toledo A, Karppinen T, Miettinen ME, et al. Narrow-band ultraviolet B (NB UV-B) exposures improve mood in healthy individuals differently depending on chronotype. Chronobiology international. 2019 ;36 (11):1570-1580. doi: 10.1080/07420528.2019.1661424.
Kondo S, Kono T, Sauder DN, et al. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. The Journal of Investigative Dermatology.1993;101(5):690-4. doi: 10.1111/1523-1747.ep12371677.
Lee WJ, Park KH, Sohn MY, et al. Ultraviolet B irradiation increases the expression of inflammatory cytokines in cultured sebocytes. The Journal of Dermatology 2013 ;40(12):993-7. doi: 10.1111/1346-8138.12330.
Collaco JM, McGrath-Morrow SA, Griffiths M. Perinatal Inflammatory Biomarkers and Respiratory Disease in Preterm Infants. The Journal of Pediatrics. 2022;246:34-39.e3. doi: 10.1016/j.jpeds.2022.04.028.
Bessler H, Kuperman A, Beilin B,et al. Labor affects cytokine production in newborns. Am J Reprod Immunol. 1998 ;39(1):27-32. doi: 10.1111/j.1600-0897.1998.tb00330.x.
Lagodka S, Petrucci S, Moretti ML, et al. Fetal and maternal inflammatory response in the setting of maternal intrapartum fever with and without clinical and histologic chorioamnionitis. American journal of obstetrics & gynecology MFM. 2022;4(2):100539. doi: 10.1016/j.ajogmf.2021.100539.
Jokic M, Guillois B, Cauquelin B, et al. Fetal distress increases interleukin-6 and interleukin-8 and decreases tumour necrosis factor-alpha cord blood levels in noninfected full-term neonates. BJOG : an international journal of obstetrics and gynaecology.2000;107(3):420-5. doi: 10.1111/j.1471-0528.2000.tb13241.x.
Tian C, Cheng L, Gu X. Cord blood TNF-α and IL-6 levels as diagnostic indicators of brain damage in neonates with non-asphyxia fetal distress. Archives of Gynecology and Obstetrics. 2017 ; 295(2):337-342. doi: 10.1007/s00404-016-4241-4.
Wu YQ, Shen J, Zhou QL, et al. Interleukin-6 and interleukin-8 in diagnosing neonatal septicemia. Journal of Biological Regulators and Homeostatic Agents. 2016 30(4):1107-1113.
Küng E, Unterasinger L, Waldhör T, et al. Cut-off values of serum interleukin-6 for culture-confirmed sepsis in neonates. Pediatr Research. 2023;93(7):1969-1974. doi: 10.1038/s41390-022-02329-9.
Gatseva P, Blazhev A, Yordanov Z, et al. Early Diagnostic Markers of Late-Onset Neonatal Sepsis. Pediatric Reports. 2023;15(3):548-559. doi: 10.3390/pediatric15030050.